Our Impact Starts with Our Community
Every milestone at The Pink Agenda begins with our community. In 2025, thousands of supporters across the country came together to fund breast cancer research, expand access to education, support those undergoing treatment, and strengthen a growing national network connected by a shared commitment to our mission. Together, we raised more than $1.9 million, brought more than 3,000 supporters together through 80 events and initiatives nationwide, and continued building on the momentum that has driven TPA since 2007.
As we head into one of the most active seasons of the year for The Pink Agenda, that community is once again at the center of everything ahead. From our signature events and educational programs to Breast Cancer Awareness Month, Team TPA at the TCS New York City Marathon, and opportunities to get involved across the country, the months ahead are a powerful reminder of what happens when our community shows up together.
Explore our 2025 Impact Report to see what your support helped make possible and where we’re headed next.
SIGNATURE EVENTS
Our Fall Gala Season Is Here
This fall, The Pink Agenda community is coming together in Chicago, New York, and Atlanta for three of our signature events. Pink on the River and our Annual New York and Atlanta Galas each feature a newly introduced Research Champion ticket, offering guests a new way to deepen their support for breast cancer research.
Pink on the River | September 27
Pink on the River returns to RPM Events on Sunday, September 27, bringing TPA Chicago together for an afternoon in support of lifesaving breast cancer research, hosted by Giuliana and Bill Rancic.
The Pink on the River Silent Auction is now live! Click here to browse and bid on an exciting lineup of experiences, dining, wellness, travel, and more, with proceeds supporting breast cancer research.
Annual New York Gala | October 8
The Pink Agenda’s Annual New York Gala returns to Tribeca Rooftop on Thursday, October 8, bringing our community together for one of our biggest nights of the year.
This year, we’re proud to honor Emmy-nominated Inside Edition correspondent, and breast cancer survivor Alison Hall with The Pink Agenda Icon Award, recognizing her commitment to using her platform to elevate conversations around breast cancer awareness and early detection.
GET YOUR TICKETS
Annual Atlanta Gala | October 22
The Pink Agenda’s Annual Atlanta Gala returns on Thursday, October 22 at The Dogwood. Join Atlanta’s TPA community for a lively night out in support of lifesaving breast cancer research.
Together, we’ll celebrate the growing strength of our Atlanta community and the role we can all play in helping change what’s possible for those affected by breast cancer.
GET YOUR TICKETS
EDUCATIONAL EVENTS
Around the Table This Fall
This fall, TPA Supper Club continues across the country, bringing together good food, leading experts, and thoughtful conversation around the issues shaping breast cancer research, prevention, treatment, survivorship, and care.
TPA Supper Club Palm Beach
Tuesday, October 20 | 5:00 PM
Del Mar – West Palm Beach
TPA Supper Club Palm Beach returns for an intimate evening around the table, featuring a cocktail reception and seated dinner in support of lifesaving breast cancer research.
We’re pleased to welcome Mehran Habibi, MD, Chief of Breast Surgery at Baptist Health Herbert Wertheim Cancer Institute, who will join us for a conversation on the latest in breast cancer research and care.
LEARN MORE & RSVP
TPA Supper Club Denver
Monday, October 26 | 6:00 PM
Grande Station
We’re bringing TPA Supper Club to Denver for the first time, featuring Carol A. Sartorius, PhD, Professor of Pathology at the University of Colorado Anschutz Medical Campus and a leading researcher in hormone receptor-positive breast cancer. Dr. Sartorius will share insights into her work and the latest advancements in breast cancer research, treatment, and care.
LEARN MORE & RSVP
TPA Supper Club Boston | Brunch Edition
Saturday, November 7 | 12:00 PM
The Nautilus
We’re thrilled to welcome Adrienne G. Waks, MD, Senior Physician and Associate Director of Clinical Research for Breast Cancer at Dana-Farber Cancer Institute, Assistant Professor of Medicine at Harvard Medical School, and a 2022 TPA-funded researcher. Dr. Waks will share insights from her work to expand treatment options and develop more individualized approaches to breast cancer care, including research focused on identifying which patients are most likely to benefit from which treatments.
[LEARN MORE & RSVP]
TPA Supper Club New York
Monday, November 16 | 6:00 PM
MM Kitchen
TPA Supper Club New York returns for an evening of good food and thoughtful conversation featuring Eleonora Teplinsky, MD, Head of Breast and Gynecologic Medical Oncology at Valley Health System and author of the new book, Beyond the Pink: Navigating Life, Health, and Breast Cancer.
Drawing from her work with patients and themes explored in her book, Dr. Teplinsky will share insights on breast cancer, health, survivorship, and navigating life during and beyond treatment.
LEARN MORE & RSVP
RESEARCH UPDATES
SUSAN M. DOMCHEK, MD
Dr. Susan Domchek is investigating how inherited BRCA1 and BRCA2 mutations may affect the immune system and influence breast cancer risk. Her team has identified differences in certain immune cells in people with BRCA mutations and is now studying healthy breast tissue for very early changes that could signal future cancer risk. These findings could ultimately uncover new opportunities to detect risk earlier and prevent breast cancer before it develops.
DAWN HERSHMAN, MD, MS, FASCO
Dr. Dawn Hershman is working to improve care and quality of life for people living with advanced and metastatic breast cancer. Her research has identified financial challenges as one factor that can affect whether patients remain on treatment and has helped pinpoint patients at greater risk of needing emergency care. Her team is now testing new approaches to support treatment adherence and studying how work disruptions after a diagnosis can affect cancer care and financial wellbeing.
NEIL IYENGAR, MD
Dr. Neil Iyengar is developing personalized lifestyle interventions to improve health and quality of life beginning at the time of a breast cancer diagnosis. Through the Healthy Living Program, patients receive individualized support around exercise, nutrition, and other lifestyle factors. Early results show improvements in wellbeing, physical and emotional functioning, and energy. His team is now expanding the program and studying how digital tools and wearable technology can make these interventions even more personalized and accessible.
KOMAL JHAVERI, MD, FACP
Dr. Komal Jhaveri is exploring a new way to make immunotherapy more effective for patients with ER-positive, HER2-negative metastatic breast cancer, a common form of the disease that has historically shown limited response to immunotherapy. Her team has completed enrollment in a clinical trial testing a novel combination of treatments and is now analyzing blood and tumor samples to identify which patients are most likely to benefit, with the goal of expanding treatment options.
IAN KROP, MD, PHD
Dr. Ian Krop is working to improve how doctors identify patients who may benefit from powerful HER2-targeted treatments. His team has developed a more sensitive test designed to detect very low levels of HER2 that standard testing may miss and is evaluating it in patients with metastatic breast cancer. The research could help more patients access effective HER2-directed therapies while also providing insight into why some cancers respond to treatment and others develop resistance.
ANN PARTRIDGE, MD, MPH
Dr. Ann Partridge is advancing research and care for younger women with breast cancer, who often face distinct medical and quality-of-life challenges. Her team’s digital support program has shown promising early results, including improved quality of life, while ongoing studies are providing important insights into fertility and pregnancy after breast cancer. Her research continues to explore why breast cancer behaves differently in younger women and how care can be better tailored to their needs.
LEADERSHIP
Applications to join The Pink Agenda’s Board of Directors and Leadership Council are now open for 2027. To receive additional information please click here or email nominating@thepinkagenda.org.
The Pink Agenda is powered by passionate professionals who are shaping the future of philanthropy. Coming from top colleges and working at leading companies, they’re not just giving their time—they’re also personally invested in our mission. Their dedication is driving real change to move breast cancer research forward, and they’re always looking for more people to join them. If you’re ready to make a difference and be part of an inspiring community, we’d love for you to get involved!